Clinical Trial Update: A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing intraperitoneal paclitaxel plus SOX versus SOX alone in gastric cancer with malignant ascites; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Neoplasms

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer, Stomach Neoplasms | Phase 3 | Status: UNKNOWN